Investec initiated coverage on shares of Georgia Healthcare Group PLC (LON:GHG) in a research note published on Wednesday morning. The firm issued a buy rating and a GBX 361 ($4.71) price target on the stock.
Other analysts also recently issued reports about the stock. Jefferies Group lifted their price objective on shares of Georgia Healthcare Group PLC from GBX 280 ($3.65) to GBX 395 ($5.16) and gave the company a buy rating in a report on Tuesday, July 26th. Numis Securities Ltd restated a buy rating and set a GBX 355 ($4.63) target price on shares of Georgia Healthcare Group PLC in a report on Friday, September 2nd.
Shares of Georgia Healthcare Group PLC (LON:GHG) traded up 1.68% during trading on Wednesday, hitting GBX 310.13. 326 shares of the stock were exchanged. The firm’s 50-day moving average is GBX 298.41 and its 200 day moving average is GBX 259.71. Georgia Healthcare Group PLC has a 1-year low of GBX 145.00 and a 1-year high of GBX 350.00. The company’s market cap is GBX 397.53 million.
About Georgia Healthcare Group PLC
Georgia Healthcare Group PLC is a United Kingdom-based holding company. The Company provides healthcare services in Georgian healthcare services market. The Company operates in two segments based on products and services: Healthcare services and Medical insurance. The Company’s Healthcare services are the inpatient and outpatient medical services delivered by the referral hospitals, community hospitals and ambulatory clinics owned by the Company throughout the Georgian territory.
Receive News & Ratings for Georgia Healthcare Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Georgia Healthcare Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.